Full Text View
Tabular View
No Study Results Posted
Related Studies
Phase I Study of BAY73-4506 in Chinese Patients With Advanced, Refractory Solid Tumors
This study has been completed.
Study NCT01096030   Information provided by Bayer

First Received on March 29, 2010.   Last Updated on January 21, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Neoplasms
Interventions listed in this trial
Regorafenib (Stivarga, BAY73-4506)
Sponsors listed in this trial
Bayer


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services